Marlborough medical device maker Boston Scientific saw a 24-percent rise in profits to $283 million in the third quarter on the back of strong growth in Europe and emerging markets.
Boston Scientific, which announced earnings Oct. 26, generated $2.2 billion in sales for the quarter, extending a strong year for the company. Sales for the first nine months of the year are up 7 percent, and profit is up more than threefold.
Boston Scientific had especially strong growth in its medical and surgical unit, which was up 10 percent year-to-year. Growth in the United States of 4 percent trailed faster growth in Europe of 11 percent and in emerging markets — 20 countries the company did not name — of 18 percent.
The third-quarter results exceeded Boston Scientific’s expectations for the period. The company said it expects sales in the fourth quarter to edge closer toward $2.4 billion, with growth of 7 percent to 8 percent.
